A detailed history of Coldstream Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Coldstream Capital Management Inc holds 29,133 shares of BMY stock, worth $1.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,133
Previous 19,809 47.07%
Holding current value
$1.7 Million
Previous $822,000 83.33%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $369,789 - $482,517
9,324 Added 47.07%
29,133 $1.51 Million
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $14,007 - $18,440
-348 Reduced 1.73%
19,809 $822,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $94,328 - $106,950
-1,966 Reduced 8.89%
20,157 $1.09 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $308,817 - $368,504
-6,370 Reduced 22.36%
22,123 $1.14 Million
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $2.9 Million - $3.24 Million
-50,016 Reduced 63.71%
28,493 $1.65 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $333,267 - $370,040
5,231 Added 7.14%
78,509 $5.02 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $2.93 Million - $3.32 Million
44,530 Added 154.9%
73,278 $5.08 Million
Q4 2022

Jan 10, 2023

BUY
$68.48 - $81.09 $419,440 - $496,676
6,125 Added 27.07%
28,748 $0
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $669,629 - $737,495
9,221 Added 68.8%
22,623 $1.74 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $355,547 - $391,582
-4,896 Reduced 26.76%
13,402 $1.03 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $16,107 - $19,314
-262 Reduced 1.41%
18,298 $1.34 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $133,216 - $155,299
2,484 Added 15.45%
18,560 $1.16 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $146,090 - $171,126
2,469 Added 18.15%
16,076 $969,000
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $228,324 - $248,644
-3,688 Reduced 21.32%
13,607 $909,000
Q1 2021

Jun 16, 2021

BUY
$59.34 - $66.74 $40,825 - $45,917
688 Added 4.14%
17,295 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $180,726 - $204,795
3,130 Added 23.22%
16,607 $1.03 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $9,016 - $9,991
-157 Reduced 1.15%
13,477 $812,000
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $29,383 - $34,352
536 Added 4.09%
13,634 $802,000
Q1 2020

May 27, 2020

SELL
$46.4 - $67.43 $9,976 - $14,497
-215 Reduced 1.61%
13,098 $730,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $200,087 - $260,996
4,066 Added 43.97%
13,313 $854,000
Q3 2019

Nov 15, 2019

BUY
$42.77 - $50.71 $18,048 - $21,399
422 Added 4.78%
9,247 $468,000
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $46,761 - $51,708
-1,048 Reduced 10.61%
8,825 $400,000
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $41,420 - $49,388
-918 Reduced 8.51%
9,873 $471,000
Q4 2018

Feb 26, 2019

SELL
$48.76 - $63.23 $17,748 - $23,015
-364 Reduced 3.26%
10,791 $561,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $7,285 - $8,217
-132 Reduced 1.17%
11,155 $693,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $60,080 - $74,883
-1,189 Reduced 9.53%
11,287 $625,000
Q1 2018

May 16, 2018

BUY
$59.92 - $68.98 $16,478 - $18,969
275 Added 2.25%
12,476 $790,000
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $90,869 - $99,070
-1,516 Reduced 11.05%
12,201 $748,000
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $58,654 - $67,691
1,062 Added 8.39%
13,717 $874,000
Q2 2017

Aug 15, 2017

BUY
N/A
12,655
12,655 $705,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.